scilogo.jpg
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
26 sept. 2024 09h05 HE | SciSparc Ltd
The intended selling valuation represents an increase of 47% from the valuation at the time of SciSparc’s initial investment in MitoCareX Bio TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- ...
Central Nervous System Treatment Market Globenewswire
With 9.4% CAGR, Central Nervous System Treatment Market Size to Surpass USD 166.53 billion by 2028
13 déc. 2023 01h03 HE | Fortune Business Insights
Pune, India, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The central nervous system treatment market is expected to grow from USD 89.02 billion in 2021 and poised to achieve a USD 166.53 billion valuation by...
AMR Logo.png
Digital Therapeutics Market Is Projected to Gain $22.60 Billion By 2031, Growing at a 19.4% CAGR: Allied Market Research
23 oct. 2023 22h00 HE | Allied Market Research
Wilmington, Delaware, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The global digital therapeutics market size was estimated at $3.84 billion and is projected to gain $22.60 billion in 2031, exhibiting a...
Coave Logo.png
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicated to its Genetic Medicine Delivery Platform
12 oct. 2023 07h00 HE | Coave Therapeutics
Paris, France, October 12th, 2023– Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, announces the formation of its new Scientific Advisory Board...
Coave Logo.png
Coave Therapeutics Appoints Genetic Medicine Expert Lolita Petit, PhD as Chief Scientific Officer
21 sept. 2023 06h00 HE | Coave Therapeutics
Paris, France, September 21, 2023 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies for CNS (Central Nervous System) and eye diseases, announces...
scilogo.jpg
SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
12 sept. 2023 09h15 HE | SciSparc Ltd
TEL AVIV, Israel, Sept. 12, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
GMILogo_Vertical-Gradient.png
Central Nervous System Therapeutics Market to hit USD 238.8 billion by 2032, says Global Market Insights Inc.
20 août 2023 20h30 HE | Global Market Insights Inc.
Selbyville, Delaware, Aug. 20, 2023 (GLOBE NEWSWIRE) -- Central Nervous System Therapeutics Market size is expected to be worth USD 238.8 billion by 2032. The growing investments in R&D...
youtube profile pic.png
Central Nervous System Treatment Market to Surpass 209.2 Billion by 2030 Drives Due to Rising Prevalence of Neurological Disorders
11 août 2023 10h30 HE | SkyQuest Technology Consulting Pvt. Ltd.
Westford,USA, Aug. 11, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, the Alzheimer's Association reports that approximately 6 million individuals in the United States are presently living with...
QMI-Logo-Long-1000px.jpg
Contract Research Organization (CRO) Market Size Worth USD 108.55 Billion By 2032 | Quince Market Insights
09 mai 2023 09h45 HE | Quince Market Insights
Pune, May 09, 2023 (GLOBE NEWSWIRE) -- Contract Research Organization (CRO) Market Size Worth USD 108.55 Billion By 2032 | Quince Market Insights According to a recent market study by Quince...
astex.png
Astex and Cardiff University Medicines Discovery Institute Announce New Drug Discovery Collaboration on Neurodegenerative Diseases
13 févr. 2023 04h00 HE | Astex Pharmaceuticals
CAMBRIDGE and CARDIFF, United Kingdom, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small...